Descriptive Analysis of Surgeries in Patients With Multiple Osteochondromas

Recruiting Observational Study
Multiple Osteochondroma
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Istituto Ortopedico Rizzoli · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Multiple Osteochondromas (MO), also known as Multiple Cartilaginous Exostoses, is an autosomal dominant skeletal disorder with an incidence of approximately 1 in 50,000 in Western populations. Most cases are associated with pathogenic variants in the EXT1 and EXT2 genes, which lead to a systemic reduction of heparan sulfate, causing abnormalities in bone growth and other physiological processes. …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with multiple osteochondromas who underwent surgery at the IOR between January 1, 2012, and February 28, 2025. * Patients of both sexes, regardless of age. Exclusion Criteria: \- Patients with conditions that are part of the differential diagnosis for the …
Contacts

Marina Mordenti, PhD

+39 051 6366062

marina.mordenti@ior.it

CONTACT